Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

56 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Recruiting

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

NCT06256575

Conditions
Connective Tissue Diseases, Digital Ulcer, Pathologic Processes, +7 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • Dalhousie University Halifax, Nova Scotia, Canada
  • Saint Joseph Health Care Centre London, Ontario, Canada
  • The Ottawa Hospital Ottawa, Ontario, Canada
View Trial Details
Active, not recruiting

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

NCT02682511

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +8 more
Locations
  • The Universtity of Arizona Arthrtis Center Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Cleveland Clinic - Florida Weston, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Efficacy and Safety of Imatinib in Scleroderma

NCT00479934

Conditions
Connective Tissue Diseases, Scleroderma, Diffuse, Scleroderma, Localized, +3 more
Locations
  • Service de Dermatologie et services de médecine interne et vasculaire - Hôpital St André - CHU de Bordeaux Bordeaux, France
  • Service de Rhumatologie, Hôpital Pellegrin-Tondu CHU de Bordeaux Bordeaux, France
  • Service de Dermatologie - CHG Libourne Libourne, France
  • Service de dermatologie - CHU de Limoges Limoges, France
View Trial Details

Related conditions